Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08CUF
|
|||
Drug Name |
PMID28766366-Compound-Scheme9EHT1610
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
DIAXONHIT LEBLOND, Bertrand CASAGRANDE, Anne-Sophie DESIRE, Laurent FOUCOURT, Alicia BESSON, Thierry
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H14FN5O2S
|
|||
Canonical SMILES |
COC1=CC(=C(C=C1)NC2=NC=NC3=C2C4=C(C=C3)N=C(S4)C(=N)OC)F
|
|||
InChI |
1S/C18H14FN5O2S/c1-25-9-3-4-11(10(19)7-9)23-17-14-12(21-8-22-17)5-6-13-15(14)27-18(24-13)16(20)26-2/h3-8,20H,1-2H3,(H,21,22,23)
|
|||
InChIKey |
RYBNARZBIXTFJS-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target Info | Inhibitor | [1] |
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B) | Target Info | Inhibitor | [1] | |
Target's Patent Info | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target's Patent Info | [1] | |
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.Expert Opin Ther Pat. 2017 Nov;27(11):1183-1199. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.